Compounds > 5,6-dihydroxy-2-dimethylaminotetralin
Page last updated: 2024-08-23

5,6-dihydroxy-2-dimethylaminotetralin and Liver Neoplasms

5,6-dihydroxy-2-dimethylaminotetralin has been researched along with Liver Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chen, Y; Kuang, M; Liao, J; Lin, S; Peng, S; Peng, Z; Wu, X; Yi, Y; Yue, X; Zhu, M1

Other Studies

1 other study(ies) available for 5,6-dihydroxy-2-dimethylaminotetralin and Liver Neoplasms

ArticleYear
Methyltransferase 1 is required for nonhomologous end-joining repair and renders hepatocellular carcinoma resistant to radiotherapy.
    Hepatology (Baltimore, Md.), 2023, 06-01, Volume: 77, Issue:6

    Topics: Carcinoma, Hepatocellular; DNA Repair; Humans; Liver Neoplasms; Methyltransferases; RNA, Transfer

2023